MedWatch

Lundbeck steers clear of international generics-trend

A number of international pharmaceutical companies have already opened business units dedicated to the sale of generic medicine. But Danish company Lundbeck refuses to jump on board.

Foto: PR lundbeck

Novartis has the subsidiary Sandoz, and Sanofi, GSK and Pfizer are all increasing their efforts. Many major drug manufacturers are now opening their own so-called copy-divisions; business units made to sell generic versions of the companies’ original products.

The world’s largest generics manufacturer, Teva, went in the opposite direction, when they bought the original manufacturer Caphalon for 6.2 million dollars.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier